Champions Oncology Inc expected to post breakeven results a share - Earnings Preview

Champions Oncology

20/07/2021 13:44

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected to show
a rise in quarterly revenue when it reports results on July 22. 
* The Baltimore, Maryland-based company is expected to report 
 a 14.6% increase in revenue to $10.03 million from $8.75
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Champions Oncology Inc
is for breakeven results per share. For the same quarter last
year, the company reported a loss of 14 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Champions
Oncology Inc is $15​, about 38.7% above​ its last closing price
of $9.20. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jan. 31 2021  0.00        0.01       0.05      Beat    649.6
 Oct. 31 2020  0.00        0.00       0.00      Met     
 Jul. 31 2020  0.02        0.02       0.01      Missed  -50​
 Apr. 30 2020              0.02       -0.14     Missed  -1,033
                                                        .3
 Jan.          0.03​       0.03       0.03      Met     12.5​
 31​ 2020​                                              
 Oct. 31 2019  -0.02       0.01       0.02      Beat    166.7​
 Jul. 31 2019  0.04        0.04       -0.05     Missed  -225
 Apr. 30 2019              0.03       -0.01     Missed  -133.3
 This summary was machine generated July 20 at 12:44 GMT.  All
figures in US dollars unless otherwise stated